黑料官网

header-logo
GettyImages-609179959-hero
headshot

Wael Saber, MD, MS

Professor

view physician profile

Locations

  • Froedtert Hospital

Specialties

  • Medical Oncology
  • Hematology

Languages

  • Arabic, English

Education

  • MD - Doctor of Medicine
  • MS -Master of Science

Biography

Dr. Wael Saber joined the faculty of 黑料官网 (黑料官网) in 2009 as an Associate Professor of Medicine in the Division of Hematology and Oncology. He is also an Assistant Scientific Director in the () at the 黑料官网, an internationally recognized research organization that focuses on outcomes related to Hematopoietic Stem Cell Transplantation (HCT).

Dr. Saber attended medical school at Ain Shams University in Egypt, and completed his internship and residency at the Cleveland Clinic Foundation. He completed an NIH T-32 research fellowship in Hematology at the University of Wisconsin in Madison. He holds a master’s degree in population health sciences from the University of Wisconsin.

Research Interests

Dr. Saber is an attending physician in the 黑料官网 adult HCT unit, with clinical interests in hematologic malignancies. His research interests are focused on outcomes related to HCT.

Publications

  • (Greenbaum U, Hashmi H, Elsawy M, Kim S, Moskop A, Oloyede T, Awan FT, Bachanova V, Badar T, Bar M, Barba P, Beitinjaneh AM, Cashen A, Dholaria B, Farooq U, Foglesong J, Ganguly S, Hematti P, Hill LC, Jain MD, Jain T, Kebriaei P, Kittai AS, Locke FL, Lulla PD, McGuirk JP, Mead E, Mussetti A, Nishihori T, Olson AL, Pennisi M, Perales MA, Geethakumari PR, Riedell PA, Saber W, Shouval R, Shpall EJ, Magalhaes-Silverman M, Strouse C, Turtle CJ, Vallurupalli A, Wudhikarn K, Pasquini MC, Ahmed S, Sorror M.) Blood Adv. 2026 Jan 13;10(1):217-227 PMID: 40811818 08/14/2025

  • (Mizuno S, Gras L, Baaij LGA, Koster L, D'Souza A, Hari PN, Estrada-Merly N, Saber W, Cowan AJ, Iida M, Okamoto S, Takamatsu H, Kawamura K, Kodera Y, Hamad N, Ko BS, Liam C, Ho KW, Goh AS, Keat TS, Elhaddad AM, Bazarbachi A, Chaudhry BQUN, Alfar R, Bekadja MA, Benakli M, Ortiz CAF, Riva E, Verburgh E, Galeano S, Bass F, Mian H, McCurdy A, Wang FR, Neumann D, Koh MBC, Snowden JA, Schönland S, McLornan DP, Hayden PJ, Balari AMS, Greinix HT, Aljurf M, Atsuta Y, Rondelli D, Niederwieser DW, Garderet L.) Haematologica. 2026 Jan 01;111(1):286-299 PMID: 40820767 PMCID: PMC12775787 SCOPUS ID: 2-s2.0-105026915369 08/18/2025

  • (Salit RB, Hexner EO, Gagelmann N, Kröger N, McLornan DP, Jain T, Gupta V, Hobbs GS, Tamari R, Robin M, Scott B, Saber W.) Leukemia. 2025 Dec;39(12):2862-2865 PMID: 41083679 PMCID: PMC12713569 SCOPUS ID: 2-s2.0-105018747447 10/14/2025

  • (Rafati M, Wang Y, Koppayi AL, Savage SA, Godley LA, Williams KM, Porter C, Jones K, Hicks B, Spellman SR, He M, Atshan R, Iwuagwu C, Bolon YT, Arrieta-Bolaños E, Saultz JN, Benjamin CL, Lee SJ, Saber W, Gadalla SM.) Am J Hematol. 2025 Dec;100(12):2442-2447 PMID: 41042026 SCOPUS ID: 2-s2.0-105018317068 10/03/2025

  • (Ustun C, Zhang MJ, Peterson A, Baek A, Agha M, Alkhateeb H, Chhabra S, Coltoff A, de Lima M, Gandhi A, Ho V, Kassim A, Lin A, Gowda L, Borthakur G, DeAngelo DJ, McGuirk J, Mensah F, Nadiminti KV, Nishihori T, Pantin J, Trunk A, Uberti J, Marcucci G, Gotlib J, Akin C, Hamadani M, Pullarkat V, Valent P, Grunwald M, Juckett M, Oran B, Saber W, Burns LJ.) Br J Haematol. 2025 Dec;207(6):2486-2495 PMID: 40983528 PMCID: PMC12519450 SCOPUS ID: 2-s2.0-105016816308 09/23/2025

  • (Spellman SR, Xu K, Oloyede T, Ahn KW, Akhtar OS, Bolon YT, Broglie L, Bloomquist J, Bupp C, Chen M, Devine SM, Jurdi NE, Hamadani M, Hengen M, Huppler AH, Jaglowski S, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Pérez WS, Phelan R, Rizzo D, Saber W, Stefanski HE, Steinert P, Tuschl E, Visotcky A, Vogel R, Auletta JJ, Shaw BE, Allbee-Johnson M.) Transplant Cell Ther. 2025 Oct 07 PMID: 41027557 PMCID: PMC12606686 SCOPUS ID: 2-s2.0-105018107118 10/01/2025

  • (Toor AA, Horton M, Khalid H, Krieger E, Lai TP, Spellman SR, Levine JE, Saber W, Stewart V, Gadalla SM.) Transplant Cell Ther. 2025 Oct;31(10):840.e1-840.e10 PMID: 40609742 PMCID: PMC12415981 SCOPUS ID: 2-s2.0-105011388715 07/04/2025

  • (Spellman SR, Xu K, Oloyede T, Ahn KW, Akhtar O, Bolon YT, Broglie L, Bloomquist J, Bupp C, Chen M, Devine SM, El-Jurdi N, Hamadani M, Hengen M, Huppler AH, Jaglowski S, Kuxhausen M, Lee SJ, Moskop A, Page KM, Pasquini MC, Perez W, Phelan R, Rizzo D, Saber W, Stefanski HE, Steinert P, Tuschl E, Visotcky A, Vogel R, Auletta JJ, Shaw BE, Allbee-Johnson M.) Transplant Cell Ther. 2025 Aug;31(8):505-532 PMID: 40398621 PMCID: PMC12302970 SCOPUS ID: 2-s2.0-105009874373 05/22/2025

  • (Zhang T, Auer P, Spellman SR, Dong J, Saber W, Bolon YT.) Life (Basel). 2025 Jun 09;15(6) PMID: 40566581 PMCID: PMC12194788 06/26/2025

  • (Arai Y, Brazauskas R, He N, Al-Homsi AS, Chhabra S, Battiwalla M, Yanada M, Steinberg A, Diaz Perez MA, Hong S, Kanda J, Bashey A, Frangoul HA, Badawy SM, Verdonck LF, Lazarus HM, Yared JA, Hashem H, Sharma A, Aljurf M, Dias AL, Abid MB, Wirk B, Freytes CO, Zeidan AM, Gergis U, Beitinjaneh A, Askar M, Pu JJ, Lehmann LE, Rangarajan HG, Wood WA, Hashmi S, Yano S, Kako S, Ozawa Y, Doki N, Kanda Y, Fukuda T, Katayama Y, Ichinohe T, Tanaka J, Teshima T, Okamoto S, Atsuta Y, Saber W.) EJHaem. 2025 Jun;6(3):e70061 PMID: 40438703 PMCID: PMC12118588 05/29/2025

  • (Mendez KJW, Lai TP, Spellman SR, Verhulst S, Anderson J, Saber W, Gadalla SM, Aviv A.) Front Immunol. 2025;16:1524608 PMID: 40364833 PMCID: PMC12069395 SCOPUS ID: 2-s2.0-105005223381 05/14/2025

  • (DeZern AE, Goll JB, Jensen TL, Nonavinkere Srivatsan S, Gillis NK, Abel GA, Padron E, Deeg HJ, Al Baghdadi T, Liu JJ, Komrokji RS, Gore SD, Saber W, Bejar R, Walter MJ, Lindsley RC, Sherman S, DiFronzo N, Sekeres MA.) Blood Neoplasia. 2024 Sep;1(3):100026 PMID: 40453059 PMCID: PMC12082164 06/02/2025

Publications of from the

© 2026 黑料官网.  All rights reserved.  | Terms and Privacy | Web Accessibility Statement

Non-Discrimination, Anti-Harassment, and Legal Compliance Statement
The 黑料官网 (黑料官网) is committed to fostering a diverse community of outstanding faculty, staff, and students, as well as ensuring equal educational opportunity, employment, and access to services, programs, and activities, without regard to an individual's race, color, national origin, religion, age, disability, sex, gender identity/expression, sexual orientation, marital status, pregnancy, predisposing genetic characteristic, military status, or other legally protected classification. 黑料官网 maintains full compliance with all applicable federal, state, and local laws and regulations in pursuit of our missions. Consistent with federal guidance, we affirm our commitment to individual merit, fairness, and equal treatment in all aspects of academic and institutional decision-making.

黑料官网's policies, federal and state laws, and regulations prohibit unlawful discrimination and harassment. Employees, learners, students, applicants, or other members of the 黑料官网 community (including but not limited to vendors, visitors, and guests) may not be subjected to harassment that is prohibited by law or treated adversely or retaliated against based upon a protected characteristic.